Business Highlights

• GAAP net income and EPS were $5.0 million and $0.14, respectively
• Non-GAAP net income of $52.3 million
• Non-GAAP EPS of $1.49
• Completed the divestiture of mobile LCD TDDI business for $120 million

SAN JOSE, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- Synaptics Incorporated (NASDAQ: SYNA), the leading developer of human interface solutions, today reported financial results for its third quarter ended March 28, 2020.

Net revenue for the third quarter of fiscal 2020 was $328.1 million. GAAP net income for the third quarter of fiscal 2020 was $5.0 million, or $0.14 per diluted share. Non-GAAP net income for the third quarter of fiscal 2020 was $52.3 million, or $1.49 per diluted share. (See below under the heading “Use of Non-GAAP Financial Information” and the attached table for a description and a reconciliation of GAAP to Non-GAAP financial measures.)

“Our focus on improving mix and controlling costs led to better than expected profitability in the March quarter despite revenue being slightly lower than anticipated as the initial impact from COVID-19 affected the supply chain and end-demand,” said Michael Hurlston, president and chief executive officer, Synaptics. “We continue to invest in our product portfolio with the goal to further improve margins and expect to remain well positioned with our customers when demand normalizes.”

Cash at March 28, 2020 was $472 million. Cash flow from operations during the third quarter of fiscal 2020 was $48 million.

Business Outlook
Dean Butler, chief financial officer of Synaptics, added, “With the TDDI divestiture completed, we are entering into the June quarter with a backlog of $240 million. Taking into consideration greater market uncertainty due to the ongoing impact from COVID-19, we believe that subsequent bookings, customer forecasts and product sell-in and sell-through patterns will result in revenue for the fourth quarter of fiscal 2020 to be in the range of $260 to $290 million. Based upon this guidance, we expect the revenue mix from mobile, IoT and PC products to be approximately 45 percent, 23 percent and 32 percent respectively.”

For the fourth quarter of fiscal 2020, the company expects:

	GAAP	Non-GAAP Adjustment	Non-GAAP
Revenue	$260M to $290M -21 percent to -12 percent Q/Q	N/A	N/A
Gross Margin	41.5 percent to 44.0 percent	Approximately $8.9M*	45 percent to 47 percent
Operating Expense	$110M to $116M	Approximately $27M to $30M**	$83M to $86M

*Projected Non-GAAP gross margin excludes $8.0 million of intangible asset amortization, $0.8 million of stock-based compensation, and $0.1 million of retention program costs.

**Projected Non-GAAP operating expense excludes $17 million to $19 million of stock-based compensation, $4 million to $5 million of restructuring costs, $3 million of retention program costs, and $3 million of intangible asset amortization.

Earnings Call and Supplementary Materials
The Synaptics third quarter and fiscal 2020 teleconference and webcast is scheduled to begin at 2:00 p.m. PT (5:00 p.m. ET), on Thursday, May 7, 2020, during which the company will provide forward-looking information.

Speakers:

• Michael Hurlston, President and Chief Executive Officer
• Dean Butler, Chief Financial Officer
• Jason Tsai, Head of Investor Relations

To participate on the live call, analysts and investors should dial 800-458-4148 (conference ID: 8994577). Supplementary slides, a copy of the prepared remarks, and a live and archived webcast of the conference call will be accessible from the “Investor Relations” section of the company’s Website at https://investor.synaptics.com/.

About Synaptics Incorporated
Synaptics is the pioneer and leader of the human interface revolution, bringing innovative and intuitive user experiences to intelligent devices. Synaptics’ broad portfolio of touch, display, biometrics, voice, audio, and multimedia products is built on the company’s rich R&D, extensive IP and dependable supply chain capabilities. With solutions designed for mobile, PC, smart home, and automotive industries, Synaptics combines ease of use, functionality and aesthetics to enable products that help make our digital lives more productive, secure and enjoyable. (NASDAQ: SYNA) www.synaptics.com.

Join Synaptics on Twitter, LinkedIn, and Facebook or visit www.synaptics.com.

Use of Non-GAAP Financial Information
In evaluating its business, Synaptics considers and uses Non-GAAP Net Income, which we define as net income excluding share-based compensation, acquisition related costs, and certain other non-cash or recurring and non-recurring items the company does not believe are indicative of its core operating performance as a supplemental measure of operating performance. Non-GAAP Net Income is not a measurement of the company’s financial performance under GAAP and should not be considered as an alternative to GAAP net income. The company presents Non-GAAP Net Income because it considers it an important supplemental measure of its performance since it facilitates operating performance comparisons from period to period by eliminating potential differences in net income caused by the existence and timing of share-based compensation charges, acquisition related costs, and certain other non-cash or recurring and non-recurring items. Non-GAAP Net Income has limitations as an analytical tool and should not be considered in isolation or as a substitute for the company’s GAAP net income. The principal limitations of this measure are that it does not reflect the company’s actual expenses and may thus have the effect of inflating its net income and net income per share as compared to its operating results reported under GAAP. In addition, the company presents components of Non-GAAP Net Income, such as Non-GAAP Gross Margin and Non-GAAP operating expenses, for similar reasons.

As presented in the “Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures” tables that follow, Non-GAAP Net Income and each of the other Non-GAAP financial measures excludes one or more of the following items:

Acquisition/divestiture related costs.
Acquisition/divestiture related costs primarily consist of:

• amortization of purchased intangibles, which includes acquired intangibles such as developed technology, customer relationships, trademarks, backlog, licensed technology, patents, and in-process technology when post-acquisition development is determined to be substantively complete,
• inventory adjustments affecting the carrying value of inventory acquired in an acquisition,
• transitory post-acquisition incentive programs negotiated in connection with an acquired business or designed to encourage post-acquisition retention of key employees, and
• legal and consulting costs associated with acquisitions or divestitures, including non-recurring post-acquisition costs and services.

These acquisition/divestiture related costs are not factored into the company’s evaluation of its ongoing business operating performance or potential acquisitions, as they are not considered as part of the company’s principal operations. Further, the amount of these costs can vary significantly from period to period based on the terms of an earn-out arrangement, revisions to assumptions that went into developing the estimate of the contingent consideration associated with an earn-out arrangement, the size and timing of an acquisition/divestiture, the lives assigned to the acquired intangible assets, and the maturity of the business acquired. Excluding acquisition/divestiture related costs from Non-GAAP measures provides investors with a basis to compare Synaptics against the performance of other companies without the variability and potential earnings volatility associated with purchase accounting and acquisition/divestiture related items.

Share-based compensation.
Share-based compensation expense relates to employee equity award programs and the vesting of the underlying awards, which includes stock options, deferred stock units, market stock units, performance stock units, phantom stock units and the employee stock purchase plan. Share-based compensation settled with stock, which includes stock options, deferred stock units, market stock units, performance stock units and the employee stock purchase plan, is a non-cash expense, while share-based compensation settled with cash, which includes phantom stock units, is a cash expense.  Settlement of all employee equity award programs whether settled with cash or stock varies in amount from period to period and is dependent on market forces that are often beyond the company’s control. As a result, the company excludes share-based compensation from its internal operating forecasts and models. The company believes that Non-GAAP measures reflecting adjustments for share-based compensation provide investors with a basis to compare the company’s principal operating performance against the performance of peer companies without the variability created by share-based compensation resulting from the variety of equity-linked compensatory awards used by other companies and the varying methodologies and assumptions used.

Restructuring costs.
Restructuring costs consist primarily of employee severance and office closure costs, including the reversal of such costs. These costs are cash-based and designed to address cost structure inefficiencies. As a result, the company excludes restructuring costs from its internal operating forecasts and models when evaluating its ongoing business performance. The company believes that Non-GAAP measures reflecting adjustments for restructuring costs provide investors with a basis to compare the company’s principal operating performance against the performance of other companies without the variability created by restructuring costs designed to address cost structure inefficiencies in its business.

Retention program costs.
Retention program costs consist of employee retention arrangement costs designed to ensure operational continuity and support through employee retention. These costs are cash-based and designed to ensure retention of certain key engineering and management employees as we transition the company through senior level management and product focus changes. As a result, the company excludes retention program costs from its internal operating forecasts and models when evaluating its ongoing business performance. The company believes that Non-GAAP measures reflecting adjustments for retention program costs provide investors with a basis to compare the company’s principal operating performance against the performance of other companies without the variability created by retention program costs designed to ensure operational continuity and support through employee retention during a transition of senior level management and product focus changes.

In-process research and development.
In-process research and development represents research and development that is not yet complete.  In the context of a business combination, in-process research and development costs will be capitalized and subsequently amortized over an estimated life or impaired.  In the context of an asset acquisition, in-process research and development costs will be expensed immediately unless there is an alternative future use.  From time to time, we may acquire in-process research and development assets as part of an asset acquisition. If determined to have no alternative future use, these in-process research and development assets will be expensed in the period acquired.  As a result, the company excludes in-process research and development costs from its internal operating forecasts and models when evaluating its ongoing business performance. The company believes that Non-GAAP measures reflecting adjustments for in-process research and development costs provide investors with a basis to compare the company’s principal operating performance against the performance of other companies without the variability created by in-process research and development costs.

Other non-cash items.
Other non-cash items includes non-cash amortization of debt discount and issuance costs. These items are excluded from Non-GAAP results as they are non-cash. Excluding other non-cash items from Non-GAAP measures provides investors with a basis to compare Synaptics against the performance of other companies without the variability associated with other non-cash items.

Recovery on sale of investment.
Recovery on sale of investment, represents the gain on the recovery of an investment in which the cost basis was previously written down to fair value. This item is excluded from Non-GAAP results as the previous write-down was excluded from Non-GAAP results. Excluding recovery on sale of investment from Non-GAAP measures provides investors with a basis to compare Synaptics against the performance of other companies without the variability associated with recovery on sale of investment.

Arbitration settlement, net
Arbitration settlement, net represents the impact of the settlement of an arbitration matter net of related legal and consulting services that is unusual or infrequent. As a result, the company excludes from its internal operating forecasts and models, when evaluating its ongoing business performance, arbitration settlement amounts net of related costs.  The company believes that Non-GAAP measures reflecting an adjustment for arbitration settlements net of related costs provides investors with a basis to compare the company’s principal operating performance against the performance of other companies without the variability created by infrequent, non-recurring or non-routine arbitration settlements net of related costs.

Equity investment loss.
Equity investment loss represents an adjustment in the book value of an equity investment in a minority owned company. The equity investment loss is a non-cash item. As a result, the company excludes equity investment loss from its internal operating forecasts and models when evaluating its ongoing business performance. The company believes that Non-GAAP measures reflecting adjustments for equity investment loss provide investors with a basis to compare the company’s principal operating performance against the performance of other companies without the variability created by non-cash items.

Non-GAAP tax adjustments.
The company forecasts its long-term Non-GAAP tax rate in order to provide investors with improved long-term modeling accuracy and consistency across financial reporting periods by eliminating the effects of certain items in our Non-GAAP net income and Non-GAAP net income per share, including the type and amount of share-based compensation, the taxation of post-acquisition intercompany intellectual property cross-licensing or transfer transactions, and the impact of other acquisition items that may or may not be tax deductible. The company intends to evaluate its long-term Non-GAAP tax rate annually for significant events, including material tax law changes in the major tax jurisdictions in which the company operates, corporate organizational changes related to acquisitions or tax planning opportunities, and substantive changes in our geographic earnings mix.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to the safe harbors created under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended.  Forward-looking statements give our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business, including our expectations regarding the potential impacts on our business of the COVID-19 pandemic, and can be identified by the fact that they do not relate strictly to historical or current facts. Such forward-looking statements may include words such as “expect,” “anticipate,” “intend,” “believe,” “estimate,” “plan,” “target,” “strategy,” “continue,” “may,” “will,” “should,” variations of such words, or other words and terms of similar meaning. All forward-looking statements reflect our best judgment and are based on several factors relating to our operations and business environment, all of which are difficult to predict and many of which are beyond our control. Such factors include, but are not limited to: the risk that our business, results of operations and financial condition and prospects may be materially and adversely affected by the COVID-19 pandemic and that significant uncertainties remain related to the impact of COVID-19 on our business operations and future results, including our fourth quarter fiscal 2020 business outlook; the risks as identified in the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Business” sections of our Annual Report on Form 10-K for the fiscal year ended June 29, 2019 (including that the impact of the COVID-19 pandemic may also exacerbate the risks discussed therein); and other risks as identified from time to time in our Securities and Exchange Commission reports. Forward-looking statements are based on information available to us on the date hereof, and we do not have, and expressly disclaim, any obligation to publicly release any updates or any changes in our expectations, or any change in events, conditions, or circumstances on which any forward-looking statement is based.  Our actual results and the timing of certain events could differ materially from the forward-looking statements. These forward-looking statements do not reflect the potential impact of any mergers, acquisitions, or other business combinations that had not been completed as of the date of this release.

For more information contact:
Jason Tsai
Head of Investor Relations
jason.tsai@synaptics.com

				SYNAPTICS INCORPORATED
				CONSOLIDATED BALANCE SHEETS
				(In millions except share data)
				(Unaudited)
					March 31,				June 30,
						2020				2019
Assets
Current assets:
	Cash and cash equivalents				$	472.1			$	327.8
	Accounts receivables, net of allowances of $1.7 at March 31, 2020 and $2.1 at June 30, 2019					238.4				230.0
	Inventories					95.5				158.7
	Current assets held for sale					12.5				-
	Prepaid expenses and other current assets					14.4				14.6
Total current assets						832.9				731.1
Property and equipment at cost, net						83.4				103.0
Non-current assets held for sale						17.6				-
Goodwill						361.8				372.8
Purchased intangibles, net						104.4				144.8
Non-current other assets						81.0				58.1
Total assets					$	1,481.1			$	1,409.8
						0.00				0.00
Liabilities and stockholders' equity
Current liabilities:
	Accounts payable				$	86.9			$	98.3
	Accrued compensation					47.7				30.4
	Income taxes payable					11.8				19.1
	Other accrued liabilities					92.8				106.1
Total current liabilities						239.2				253.9
Convertible notes, net						482.0				468.3
Non-current portion of acquisition-related liabilities						1.3				-
Other long-term liabilities						45.7				30.3
Total liabilities						768.2				752.5
				0
Commitments and contingencies
Stockholders' equity:
	Preferred stock;
		$.001 par value; 10,000,000 shares authorized;
			no shares issued and outstanding			-				-
	Common stock;
		$.001 par value; 120,000,000 shares authorized;
			65,752,215 and 64,283,948 shares issued, and 34,004,920 and
			33,349,735 shares outstanding, respectively			0.1				0.1
	Additional paid in capital					1,323.9				1,266.1
	Less: 31,747,295and 30,934,213 treasury shares, respectively, at cost					(1,222.5	)			(1,192.4	)
	Retained earnings					611.4				583.5
Total stockholders' equity						712.9				657.3
Total liabilities and stockholders' equity					$	1,481.1			$	1,409.8

SYNAPTICS INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions except per share data)
(Unaudited)
					Three Months Ended									Nine Months Ended
					March 31,								March 31,
						2020				2019				2020				2019
Net revenue					$	328.1			$	334.0			$	1,056.3			$	1,177.1
Acquisition related costs (1)						8.1				15.2				31.6				47.3
Cost of revenue						184.4				202.8				603.6				723.1
Gross margin						135.6				116.0				421.1				406.7
Operating expenses
	Research and development					75.8				82.4				235.1				256.0
	Selling, general, and administrative					31.6				34.1				90.6				103.1
	Acquisition related costs (2)					2.9				3.0				8.8				10.2
	Restructuring costs (3)					6.3				0.3				26.2				10.4
	In-process research and development charge					-				-				3.7				-
Total operating expenses						116.6				119.8				364.4				379.7
Operating income						19.0				(3.8	)			56.7				27.0
Interest and other income, net						(3.2	)			(4.3	)			(9.1	)			(10.5	)
Income before income taxes						15.8				(8.1	)			47.6				16.5
Provision for income taxes						10.2				(15.3	)			17.3				(8.1	)
Equity investment loss						(0.6	)			(0.5	)			(1.5	)			(1.3	)
Net income					$	5.0			$	6.7			$	28.8			$	23.3
Net income per share:
	Basic				$	0.15			$	0.19			$	0.86			$	0.67
	Diluted				$	0.14			$	0.19			$	0.83			$	0.66
Shares used in computing net income per share:
	Basic					34.0				34.4				33.5				34.7
	Diluted					35.0				35.0				34.5				35.5

	(1)		These acquisition related costs consist primarily of amortization of acquired intangible
			assets and inventory fair value adjustments associated with acquisitions.
	(2)		These acquisition related costs, net consist primarily of amortization associated with certain
			acquired intangible assets as well as transitory acquisition related compensation plans.
	(3)		Restructuring costs primarily include severance costs and facility consolidation
			costs associated with operational restructurings and acquisitions.

SYNAPTICS INCORPORATED
Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures
(In millions except per share data)
(Unaudited)
				Three Months Ended								Nine Months Ended
				March 31,								March 31,
					2020				2019				2020				2019
GAAP gross margin				$	135.6			$	116.0			$	421.1			$	406.7
	Acquisition related costs				8.1				15.2				31.6				47.3
	Loss/(recovery) on supply commitment				-				-				(3.0	)			-
	Retention costs				0.1				-				0.4				-
	Share-based compensation				0.8				0.7				2.1				2.4
Non-GAAP gross margin				$	144.6			$	131.9			$	452.2			$	456.4
GAAP gross margin - percentage of revenue					41.3	%			34.7	%			39.9	%			34.6	%
	Acquisition related costs - percentage of revenue				2.5	%			4.6	%			2.9	%			4.0	%
	Loss/(recovery) on supply commitment				0.0	%			-				-0.3	%			0.0	%
	Retention costs				0.0	%			-				0.0	%			0.0	%
	Share-based compensation - percentage of revenue				0.2	%			0.2	%			0.2	%			0.2	%
Non-GAAP gross margin - percentage of revenue					44.1	%			39.5	%			42.8	%			38.8	%
GAAP research and development expense				$	75.8			$	82.4			$	235.1			$	256.0
	Share-based compensation				(9.0	)			(8.6	)			(24.6	)			(25.4	)
	Retention costs				(2.2	)			-				(6.6	)			-
	In-process research and development charge				-				-				(3.7	)			-
Non-GAAP research and development expense				$	64.6			$	73.8			$	203.9			$	230.6
GAAP selling, general, and administrative expense				$	31.6			$	34.1			$	90.6			$	103.1
	Share-based compensation				(8.1	)			(6.5	)			(17.5	)			(20.9	)
	Acquisition/divestiture related costs				(0.3	)			(2.2	)			(1.7	)			(3.4	)
	Retention costs				(1.1	)			-				(3.9	)			-
	Arbitration settlement, net				-				-				-				1.7
Non-GAAP selling, general, and administrative expense				$	22.1			$	25.4			$	67.5			$	80.5
GAAP operating income				$	19.0			$	(3.8	)		$	56.7			$	27.0
	Share-based compensation				17.9				15.8				44.2				48.7
	Acquisition/divestiture related costs				11.3				20.4				42.1				60.9
	Loss/(recovery) on supply commitment				-				-				(3.0	)			-
	Restructuring costs				6.3				0.3				26.2				10.4
	Retention costs				3.4				-				10.9				-
	In-process research and development charge				-				-				3.7				-
	Arbitration settlement, net				-				-				-				(1.7	)
Non-GAAP operating income				$	57.9			$	32.7			$	180.8			$	145.3
GAAP net income				$	5.0			$	6.7			$	28.8			$	23.3
	Share-based compensation				17.9				15.8				44.2				48.7
	Acquisition/divestiture related costs				11.3				20.4				42.1				60.9
	Loss/(recovery) on supply commitment				-				-				(3.0	)			-
	Restructuring costs				6.3				0.3				26.2				10.4
	Retention program costs				3.4				-				10.9				-
	In-process research and development charge				-				-				3.7				-
	Arbitration settlement, net				-				-				-				(1.7	)
	Other non-cash items				4.7				4.5				14.0				13.4
	Recovery on sale of investment				-				-				-				(2.8	)
	Equity investment loss				0.6				0.5				1.5				1.3
	Non-GAAP tax adjustments				3.1				(19.2	)			(5.0	)			(25.5	)
Non-GAAP net income				$	52.3			$	29.0			$	163.4			$	128.0
GAAP net income per share - diluted				$	0.14			$	0.19			$	0.83			$	0.66
	Share-based compensation				0.51				0.45				1.28				1.37
	Acquisition/divestiture related costs				0.32				0.53				1.22				1.66
	CEO severance				-				0.06				-				0.06
	Loss/(recovery) on supply commitment				-				-				(0.09	)			-
	Restructuring costs				0.18				-				0.76				0.29
	Retention program costs				0.10				-				0.32				-
	In-process research and development charge				-				-				0.11				-
	Arbitration settlement, net				-				-				-				(0.05	)
	Other non-cash items				0.13				0.13				0.41				0.38
	Recovery on sale of investment				-				-				-				(0.08	)
	Equity investment loss				0.02				0.02				0.04				0.04
	Non-GAAP tax adjustments				0.09				(0.55	)			(0.14	)			(0.72	)
Non-GAAP net income per share - diluted				$	1.49			$	0.83			$	4.74			$	3.61

SYNAPTICS INCORPORATED
CONDENSED CONSOLIDATED CASH FlOWS
(In millions)
(Unaudited)
		Nine Months Ended
		March 31,
			2020				2019
Net income		$	28.8			$	23.3
Non-cash operating items			119.0				130.2
Changes in working capital			20.5				(42.7	)
Provided by operations			168.3				110.8
Acquisitions			(2.5	)			-
Fixed asset & intangible asset purchases			(11.7	)			(17.7	)
Proceeds from sales and maturities of investments			-				2.8
Used in investing			(14.2	)			(14.9	)
Treasury shares purchased			(30.1	)			(77.3	)
Equity compensation, net			20.5				4.2
Used in financing			(9.6	)			(73.1	)
Effect of exchange rate changes on cash and cash equivalents			(0.2	)			-
Net change in cash and cash equivalents			144.3				22.8
Cash and cash equivalents at beginning of period			327.8				301.0
Cash and cash equivalents at end of period		$	472.1			$	323.8
Cash paid for taxes		$	24.0			$	16.1
Cash refund on taxes		$	1.3			$	5.2